Article

A Potential Role for the Ketogenic Diet in Alzheimer’s Disease Treatment: Exploring Pre-clinical and Clinical Evidences

2023-11-24

Abstract excerpt

Given the remarkable progress in global health and overall quality of life, the significant rise in life expectancy has become intertwined with the surging occurrence of neurodegenerative disorders (ND). This emerging trend is poised to pose a substantial challenge to the fields of medicine and public health in the years ahead. In this context, Alzheimer's disease (AD) is regarded as a ND that causes recent m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ffc8beb2-64ca-5658-889a-65d1267ceff4
DOI: 10.20944/preprints202311.1556.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Potential Role for the Ketogenic Diet in Alzheimer’s Disease Treatment: Exploring Pre-clinical and Clinical EvidencesDOI 10.20944/preprints202311.1556.v1Read

Searching the Linkage between High Fat Diet and Alzheimer′s Disease: A Debatable Proof Stand for Ketogenic Diet to Alleviate Symptoms of Alzheimer′s Patient with APOE ε4 AlleleSemantic proximity Read

Dietary prospects of coconut oil for the prevention and treatment of Alzheimer's disease (AD): A review of recent evidencesSemantic proximity Read

Ketogenic Diet in Neuromuscular and Neurodegenerative DiseasesSemantic proximity Read

Alzheimer’s Disease and NutritionSemantic proximity Read

Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegenerationSemantic proximity Read

Requirement for oxidation of neuronal ketone bodies in aging and neurodegenerationSemantic proximity Read

Autophagy Dysfunction and its Link to Alzheimer’s Disease and Type II Diabetes MellitusSemantic proximity Read

Multifactorial Therapeutic Strategies Targeting Advanced Glycation End-Products, Oxidative Stress, and Metabolic Dysfunction in Alzheimer's DiseaseSemantic proximity Read

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and DiabetesSemantic proximity Read

Alzheimer’s Disease and Type 2 Diabetes Relationships. I. Cellular and Molecular Common Pathological MechanismsSemantic proximity Read

Exenatide reverts the high-fat-diet-induced impairment of BDNF signaling and inflammatory response in an animal model of Alzheimer’s diseaseSemantic proximity Read

Ketogenic interventions restore cognition and modulate peripheral metabolic dysfunctions in Alzheimer’s disease mouse modelsSemantic proximity Read